MedTrace Logo

Preoperative i.v. Iron Substitution in Patients With Colon Cancer

NCT04653181 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 514

Last updated 2024-02-29

No results posted yet for this study

Summary

About 70% of colon cancer patients are anemic. Preoperative anemia in patients with colorectal cancer is associated with both impaired disease-free survival and overall survival. The purpose of this study is to compare the effects of preoperative iv iron substitution on postoperative recovery in preoperatively anemic (male Hb \<130, female Hb \<120) and iron deficient colon cancer patients in a prospective setup. As a primary outcome, the effect of iv-iron substitution on postoperative complications is investigated.

Conditions

Interventions

DRUG

Ferric carboxymaltose

Iron-arm treated with Ferric carboxymaltose, non-iron arm without

Sponsors & Collaborators

  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Selja K Koskensalo, Md, PhD · Abdominal centre, HUCH

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2024-12-31
Completion
2025-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04653181 on ClinicalTrials.gov